Saving Second Base: Recapping Our Second Innovators

Over the past weeks, we’ve introduced four additional innovators at the forefront of cancer:

ONCO-LIQ – Cancer detection through routine blood testing

TELEXOS – Improved cancer diagnostics through detection of circulating tumor cells in blood

BETAGLUE – Treatment for cancer tumor margins to ensure eradication

INHERET – Self-administered genetic risk profiling

We want to invite you to help us determine which innovation is more important to support, and possibly invest in. 

Would you take a few minutes to watch the recap video below and let us know which of these is most important to support by clicking here to take our very short survey?


Submit a Comment

Your email address will not be published. Required fields are marked *